FindTrial
Sign In

M518101 phase 2b study in plaque psoriasis patients - comparison study 3 -

M518101 phase 2b study in plaque psoriasis patients - comparison study 3 -

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222091
Enrollment
Unknown
Registered
2013-05-27
Start date
2013-05-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plaque psoriasis

Interventions

investigational material(s) Generic name etc : M518101 INN of investigational material : Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational mater

Sponsors

Maruho Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with plaque psoriasis. Outpatient.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
severity of plaque psoriasis—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026